Dividend Dispatch — Today's Theme
|
Today's Theme
|
|
📊 The Friday Roundup — Five Picks, One Email
|
|
Every Friday I do the same thing: pull out my single best pick from each of the five sections we run all week. One high yield. One Aristocrat. One growth star. One weird yield. One safe name. This week I screened covered-call ETFs, verified AbbVie's ex-dividend calendar, looked into a healthcare company that just raised its dividend 25%, and went deep on a REIT that buys places where people go to have fun — including seven theme parks it just acquired from Six Flags. The S&P closed yesterday at 7,544. VIX is at 15.87. Nothing dramatic — but there's an ex-dividend deadline next week you should know about. Let's get to it.
|
|
|
|
Big Oil Bet $35M on Lithium. It Could Reach $225M
Eni, Italy’s largest oil producer, just signed a strategic agreement to invest into EnergyX’s lithium project in Chile, a stake that could reach $225M. The project is expected to generate $1.3B in annual revenue at forecasted market prices.
It’s just one piece of EnergyX’s portfolio holding up to 15M+ tons of untapped lithium, and it’s the latest proof of EnergyX’s progress. Until July 16, you can invest as an early-stage shareholder and share in that growth.
Natural resources weren’t the only draw. EnergyX’s patented tech recovers up to 3X more lithium than traditional methods at 500X the speed, paving the way to commercial-scale production.
Lithium demand is projected to grow 5X by 2040, so the timing couldn’t be better. General Motors and POSCO are already EnergyX shareholders.
Dividend Dispatch — Section 1a
|
|
The High Yield
Today's best dividend income ideas — 8%+ yields only
|
|
JEPIThe Covered-Call ETF That Sends $69 a Month on $10K
|
JPMorgan Equity Premium Income ETF is the biggest covered-call ETF in the world — $44 billion in assets. Here's how it works: JEPI holds a basket of defensive large-cap stocks, then uses structured products called equity-linked notes that mimic the payoff of selling covered calls on the S&P 500. A covered call is like renting out a room in your house. You give up some space — in this case, some stock upside — in exchange for monthly cash.
And JEPI sends that cash every single month. At $56.75 a share, the distribution yield is running at 8.3%. That's $830 a year on a $10,000 position — about $69 every month landing in your account.
Here's the trade-off I have to be honest about: in a strong bull market, JEPI lags the S&P 500 because those sold calls cap your gains. If the market rips 20% in a year, JEPI won't keep up. But if you're building for income — not maximum price appreciation — $69 a month from a diversified basket of blue chips is a solid deal.
|
|
Yield: 8.3%
|
$10K invested = $830/yr
|
Paid: Monthly
|
|
|
|
|
|
Dividend Aristocrats
The blue-chip legacy payers
|
|
ABBV54 Years of Raises — and Going Ex-Dividend Wednesday
|
AbbVie is a pharmaceutical company behind some of the biggest-selling drugs on the planet. Skyrizi brought in $4.48 billion last quarter — up 31% year over year. Rinvoq added $2.12 billion, up 23%. Those two have more than replaced what AbbVie lost when Humira's patents expired and biosimilar competitors flooded in. Management raised full-year EPS guidance to $14.08–$14.28.
The dividend streak is 54 consecutive years when you count the Abbott Labs lineage (AbbVie spun off from Abbott in 2013). The quarterly payout is $1.73 — $6.92 a year — good for a 2.72% yield. On $10,000, that's $272 a year.
Here's the timing angle: the ex-dividend date is next Wednesday, July 15. An ex-dividend date is the cutoff — you need to own shares by the day before the ex-date to receive the payment. So if ABBV is on your list, Tuesday's close is your deadline for this quarter's $1.73.
The risk: AbbVie rallied 14% in the last month alone. You're paying up at these prices. The balance sheet carries negative shareholders' equity, and Humira revenue dropped 50% in fiscal 2025. I own this one, but I bought it lower.
|
|
Yield: 2.72%
|
$10K invested = $272/yr
|
Paid: Quarterly
|
|
|
|
|
|
Dividend Growth Stars
Fast-rising income builders
|
|
DHR25% Raise — From a Name Most Dividend Investors Overlook
|
Danaher makes instruments and consumables for pharmaceutical companies, biotech labs, and water treatment facilities. Not the kind of company that shows up at dinner parties. But here's what does show up: a 25% dividend increase — the most recent one. That's not a typo.
And it's not an outlier. Danaher's 10-year compound annual growth rate — the CAGR, which is just the average yearly increase smoothed out over a decade — is 14.3%. At that pace, the dividend doubles roughly every five years. They've raised 13 straight years, and the raises are getting bigger, not smaller.
The current yield is tiny — 0.82%, which gives you $82 a year on $10,000. I know, that won't pay any bills today. But this is the Growth Stars section, where trajectory matters more than today's check. What's $82 today at a 14.3% growth rate becomes roughly $164 in five years, then around $328 five years after that. That's compounding — slow at first, then fast.
The risk: Danaher's end markets — biotech and pharma R&D spending — slow in economic downturns. And at around $195 a share, it's not a bargain.
|
|
Yield: 0.82%
|
$10K invested = $82/yr
|
Paid: Quarterly
|
|
|
|
|
|
Emmy-Winning Analyst Releases His Next Big Story
Whitney Tilson shocked the nation on 60 Minutes when he accused a major company of poisoning its customers. The investigation won an Emmy and the stock fell nearly 80%. (He also called the housing crisis and the collapse of Bear Stearns and Lehman Brothers). Now, he's releasing his next big story. He says a dangerous pattern is forming, and most Americans have no idea how exposed they really are. For the full presentation, go here.
Dividend Dispatch — Section 1b
|
|
The Weird Yield
Income from places you'd never expect
|
|
EPRThis REIT Owns Roller Coasters, Movie Theaters, and Ski Resorts
|
I love telling people about this one because the reaction is always the same: wait, you can get paid from roller coasters?
EPR Properties is an experiential REIT — a real estate investment trust, which is a company that owns properties and is legally required to distribute at least 90% of its taxable income as dividends. But while most REITs own office buildings or apartments, EPR owns the places where people go to have fun. Movie theaters. TopGolf-style entertainment centers. Ski resorts. Waterparks. And as of April 2026, seven regional theme parks acquired from Six Flags for $315 million.
The portfolio is 99% leased, total assets are $5.7 billion, and 94% of it is experiential. EPR pays $0.31 per share every month — $3.72 a year — for a 6.2% yield. That's $620 a year on $10,000, showing up in twelve monthly installments of about $52.
The risk is real: EPR is tied to discretionary consumer spending. If people pull back on movies, ski trips, and theme parks, tenants can struggle to cover rent. AMC is a significant tenant in their theater portfolio — and their financial health is always worth watching.
|
|
Yield: 6.2%
|
$10K invested = $620/yr
|
Paid: Monthly
|
|
|
|
|
|
Safety & Watchlist
Reliable picks + red flags
|
|
Safe Pick
|
|
TROW40 Consecutive Years of Raises and a 55% Payout Ratio
|
T. Rowe Price Group is one of the largest publicly traded asset managers in the country. Founded in 1937 in Baltimore, managing $1.7 trillion as of March 2026. They run mutual funds, retirement plans, and institutional accounts.
Here's why TROW earns the safe label: 40 consecutive years of dividend increases. The most recent — a 2.4% raise in February 2026 — brought the quarterly payout to $1.30, or $5.20 a year. At current prices, that's a 4.4% yield, which puts $440 a year in your pocket on $10,000 invested.
The payout ratio is 55%. That means for every dollar T. Rowe earns, they pay out 55 cents as dividends and keep 45 cents for growth and a rainy day. That's a healthy cushion — they could take a real hit to earnings and still cover the dividend. Q1 2026 revenue hit $1.86 billion, up 5.3%, and earnings of $2.52 per share beat estimates by $0.17.
The risk with any asset manager: when markets drop, assets under management shrink, fees fall, and earnings follow. In 2022, TROW shares got hit hard when the bear market shrank AUM. But they raised the dividend that year — and the 35 years before that, too.
|
|
Yield: 4.4%
|
$10K invested = $440/yr
|
Paid: Quarterly
|
|
|
|
|
|
Dividend Dispatch — Main Rest
|
|
The Extra Yield
This week's calendars, screens & answers
|
|
Ex-dividend deadline: AbbVie (ABBV) goes ex-dividend Wednesday, July 15. If you want the $1.73 quarterly payment, own shares by Tuesday's close. Abbott Labs (ABT) also goes ex-dividend July 15 — $0.63 per share.
|
|
Screen I ran this week: I filtered covered-call ETFs for 8%+ yield and at least $10 billion in assets under management. JEPI at $44 billion was the clear standout. Some alternatives yield more on paper, but have lost NAV value over time — which means the sticker yield overstates what you're actually earning.
|
|
Number that stuck with me: EPR Properties' portfolio is 99% leased. For a REIT built on movie theaters and entertainment venues — industries everyone was writing off five years ago — that 99% number is worth sitting with.
|
|
|
|
The Dispatch
|
|
That's the full week. JEPI for high yield at 8.3%. AbbVie for the Aristocrat with a Wednesday ex-dividend deadline. Danaher for growth — that 25% raise is hard to ignore. EPR Properties for the weirdest income story I found all week. And T. Rowe Price for 40 years of safety at a 4.4% yield. Monday we're back with two fresh high-yield picks and the Safety & Watchlist. Enjoy the weekend.
|
|
— Charlie
|
|
|
|
*Disclaimer: Energy Exploration Technologies, Inc. (“EnergyX”) has engaged [Dividend Dispatch] to publish this communication in connection with EnergyX’s ongoing Regulation A offering. [Dividend Dispatch] has been paid $250 per lead___ in cash and may receive additional compensation. [Dividend Dispatch] and/or its affiliates do not currently hold securities of EnergyX.
This compensation and any current or future ownership interest could create a conflict of interest. Please consider this disclosure alongside EnergyX’s offering materials. EnergyX’s Regulation A offering has been qualified by the SEC. Offers and sales may be made only by means of the qualified offering circular. Before investing, carefully review the offering circular, including the risk factors. The offering circular is available at invest.energyx.com/. Comparisons to other companies are for informational purposes only and should not imply similar results.